BofA raised the firm’s price target on Eastman Chemical (EMN) to $75 from $74 and keeps a Buy rating on the shares. 2026 earnings tailwinds such as cost savings and an asset utilization ramp are material enough to lead to earnings improvement from 2025, even if end-market demand remains sluggish and the company continues to focus on cash generation at the expense of profits, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
